Latest intangible assets for XLO: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Xilio Therapeutics (XLO) currently reports a intangible assets of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Xilio Therapeutics's intangible assets history and peer comparisons.
Xilio Therapeutics's intangible assets changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Xilio Therapeutics reported $0 in intangible assets as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current intangible assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Xilio Therapeutics, and consider following XLO for alerts when major investors trade the stock.
Xilio Therapeutics is classified in the Healthcare sector. On intangible assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing XLO with unrelated industries.